Cryo-EM structure of the Plasmodium falciparum 80S ribosome bound to the anti-protozoan drug emetine

Wilson Wong, Xiao‐chen Bai, Alan Brown, I.s. Fernandez, Eric Hanssen, Melanie Condron, Yan Tan, Jake Baum, Sjors H. W. SchereseLife 2014 · DOI

TL;DR

Researchers have determined the first atomic-resolution cryo-EM structure of the Plasmodium falciparum (malaria parasite) 80S ribosome bound to the anti-protozoan drug emetine. This breakthrough provides crucial insights into how emetine inhibits parasite protein synthesis and establishes cryo-EM as a powerful tool for designing new anti-malarial drugs.

What Problem Does This Paper Address?

Malaria remains a devastating global health issue, with drug-resistant parasite strains posing a significant challenge. Repurposing existing drugs is a promising strategy to accelerate the development of new treatments. Emetine, an anti-amoebic drug, has shown potent anti-malarial activity by inhibiting protein translation, but its precise mechanism of action and potential for off-target toxicity in humans have limited its use. To address this, the researchers aimed to visualize the interaction between emetine and the malaria parasite's ribosome at an atomic level, seeking to understand its binding site and identify potential avenues for developing safer and more effective anti-malarial therapies.

Methods

The study employed cryo-electron microscopy (cryo-EM) to determine the structure of the Plasmodium falciparum 80S ribosome in complex with emetine. This technique involves rapidly freezing samples and imaging them with electrons to capture high-resolution structural information. The researchers utilized advanced cryo-EM techniques, including direct electron detection and statistical image processing, to achieve an overall resolution of 3.2 Å. This allowed for the construction of a detailed all-atom model of the ribosome-emetine complex. To pinpoint emetine's binding site, a difference map was calculated between reconstructions of the ribosome with and without the drug.

Datasets

Not discussed in the paper. The study generated its own datasets from purified P. falciparum ribosomes.

Key Insights and Ideas

  • First Atomic-Resolution Structure of a Parasitic Ribosome-Drug Complex: This work represents a significant milestone, providing the first detailed structural view of an antibiotic bound to any ribosome at atomic resolution.
  • Emetine Binds to the E-site: Emetine was found to bind to the E-site of the ribosomal small subunit, a crucial region involved in tRNA binding and translocation.
  • Shared Binding Site with Pactamycin: The binding pocket for emetine is remarkably similar to that of pactamycin, another antibiotic known to inhibit protein synthesis. This suggests a common mechanism of action and opens possibilities for developing drugs that target this shared site.
  • Potential for Drug Repurposing and Design: The detailed structural information allows for the rational design of emetine derivatives or novel compounds that specifically target the parasite ribosome, potentially reducing toxicity to human cells.
  • Cryo-EM as a Powerful Drug Discovery Tool: The success of this study highlights the growing power of cryo-EM in visualizing drug-target interactions, even for large and complex molecular machines like ribosomes, bypassing the challenges of crystallization.

Key Results

The study successfully determined the cryo-EM structure of the Plasmodium falciparum 80S ribosome bound to emetine at 3.2 Å resolution. This enabled the construction of a fully refined all-atom model. The structure revealed that emetine binds to the E-site of the small ribosomal subunit, interacting with specific rRNA helices (h23, h24, h45) and the C-terminus of ribosomal protein uS11. This binding pocket is conserved between P. falciparum and human ribosomes, explaining some of the observed toxicity. However, the study also identified Plasmodium-specific features in the ribosome that could be exploited for targeted drug development. The difference map clearly showed a single, continuous feature corresponding to the emetine molecule.

Limitations and Future Work

The authors acknowledge that while the emetine binding site is conserved between parasite and human ribosomes, suggesting a shared mechanism of toxicity, modifications to emetine or related compounds could potentially reduce cytotoxicity. They suggest that compounds targeting this binding site are amenable to optimization. Future work could focus on designing and testing emetine derivatives or other molecules that exploit the Plasmodium-specific features of the ribosome to achieve greater selectivity and reduced host toxicity. The study also highlights the potential for using cryo-EM to investigate other anti-malarial drugs and to understand resistance mechanisms.

Summary updated

Abstract

Malaria inflicts an enormous burden on global human health. The emergence of parasite resistance to front-line drugs has prompted a renewed focus on the repositioning of clinically approved drugs as potential anti-malarial therapies. Antibiotics that inhibit protein translation are promising candidates for repositioning. We have solved the cryo-EM structure of the cytoplasmic ribosome from the human malaria parasite, Plasmodium falciparum, in complex with emetine at 3.2 Å resolution. Emetine is an anti-protozoan drug used in the treatment of ameobiasis that also displays potent anti-malarial activity. Emetine interacts with the E-site of the ribosomal small subunit and shares a similar binding site with the antibiotic pactamycin, thereby delivering its therapeutic effect by blocking mRNA/tRNA translocation. As the first cryo-EM structure that visualizes an antibiotic bound to any ribosome at atomic resolution, this establishes cryo-EM as a powerful tool for screening and guiding the design of drugs that target parasite translation machinery.
BibTeX
@inproceedings{wong2014cryo,
  author = {Wilson Wong and Xiao‐chen Bai and Alan Brown and I.S. Fernandez and Eric Hanssen and Melanie Condron and Yan Tan and Jake Baum and Sjors H. W. Scheres},
  title = {{Cryo-EM structure of the Plasmodium falciparum 80S ribosome bound to the anti-protozoan drug emetine}},
  booktitle = {eLife},
  year = {2014},
  doi = {10.7554/elife.03080},
}
Figure